Lower Number of Fludarabine Cycles in Patients with Lymphoid Malignancies
Fludarabine, a nucleoside analog, is commonly used to treat lymphoid malignancies. While the optimal number of cycles of fludarabine per treatment course is not known, common strategies include treatment for 6 cycles or 2-3 cycles past best or complete response. This study is a retrospective revie...
Saved in:
| Main Author: | Donald Pasquale |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
PAGEPress Publications
2014-08-01
|
| Series: | Mediterranean Journal of Hematology and Infectious Diseases |
| Subjects: | |
| Online Access: | https://mjhid.org/index.php/mjhid/article/view/1810 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
First research of use Vero-Fludarabine in chronic lymphocytic leukemia and non-hodgkins lymphoma
by: S. S. Bessmeltsev, et al.
Published: (2022-11-01) -
Treatment of patients with refractory chronic lymphocytic leukemia with alemtuzumab, alone or in combination with fludarabine
by: E. V. Kataeva, et al.
Published: (2014-07-01) -
Inferior Outcomes of Fludarabine–Cyclophosphamide–Rituximab Chemotherapy in Korean Chronic Lymphocytic Leukemia Patients with Concurrent Thrombocytopenia and Anemia
by: Tong-Yoon Kim, et al.
Published: (2025-01-01) -
ALLOGENEIC TRANSPLANTATION FOR CHRONIC LYMPHOCYTIC LEUKEMIA
by: Luca Laurenti, et al.
Published: (2010-08-01) -
Initial renal function and type of chemotherapy: impact on treatment efficacy in patients with chronic lymphocytic leukemia
by: A. K. Nikitina, et al.
Published: (2015-06-01)